BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 10192881)

  • 1. Clinical aspects of multiple myeloma and related disorders including amyloidosis.
    Kyle RA
    Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma: diagnosis and treatment.
    Nau KC; Lewis WD
    Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3. The laboratory investigation of monoclonal gammopathies.
    Kyle RA; Greipp PR
    Mayo Clin Proc; 1978 Nov; 53(11):719-39. PubMed ID: 101720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary amyloidosis associated with kappa light chain myeloma].
    Martins RG; Roncon-Albuquerque R; Cabral R; Frazão J; Von Hafe P
    Acta Med Port; 2010; 23(2):281-4. PubMed ID: 20470479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: clinical features and indications for therapy.
    Dispenzieri A; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):553-68. PubMed ID: 16026737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
    Miralles GD; O'Fallon JR; Talley NJ
    N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The laboratory diagnosis of plasma cell myeloma and related disorders.
    Nawab RA; Azar HA
    Orthop Clin North Am; 1979 Apr; 10(2):391-404. PubMed ID: 109804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.
    Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE
    Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system].
    Westerhausen M
    Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level].
    Kanoh T
    Rinsho Ketsueki; 1996 Dec; 37(12):1416-21. PubMed ID: 8997132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis].
    Kanoh T; Yago K; Okuma M
    Rinsho Ketsueki; 1990 Oct; 31(10):1740-4. PubMed ID: 2255066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):71-87. PubMed ID: 9081205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of measurement of free light chains].
    Matsuda M
    Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.